Abacus Diagnostica Oy is a Finnish molecular diagnostics company specialized in rapid molecular testing utilizing the patented GenomEra® -technology.
Our company is located in the dynamic Science Park area with a strong focus in life sciences in the city of Turku at the Southwest coast of Finland.
Abacus’ vision is to provide cost-effective and easy-to-use products to enable molecular diagnostics also in resource and capability limited settings. Our solutions enables routine molecular diagnostics without compromising the quality of results and move the molecular diagnostics to the next level of simplicity. Customers’ needs is our core value with every single step.
Abacus Diagnostica Oy was founded in 2004 by the inventors of the GenomEra® -technology at the Department of Biotechnology at the University of Turku. We are currently developing new technologies and expanding assay selection for the GenomEra® CDX assay platform, intended for the identification of infectious diseases like Influenza, C. difficile, MRSA and other critical human pathogens and antibiotic resistance markers.
Our quality policy is designed according to the highest possible safety standards. Quality guides all our operations and is the responsibility of every function of the organization. Commitment of safety and high quality is monitoring and maintaining with effective quality systems and process metrics throughout all functions of the organization. We are dedicated to continuous improvement of our systems, processes, and products.
Abacus Diagnostica Oy is ISO 13485 certified, and holds a strong IPR position covering the key strengths of the GenomEra® -technology.